Premenstrual syndrome and premenstrual dysphoric disorder

被引:2
作者
Kovacs Zoltan [1 ,2 ]
Hegyi Gabriella [2 ]
Szoke Henrik [2 ]
机构
[1] Robert Magankorhaz, Szuleszeti Osztaly, Budapest, Hungary
[2] Pecsi Tud Egyet, Egeszsegtud Kar, Egeszsegtud Doktori Iskola, Pecs, Hungary
关键词
premenstrual syndrome; premenstrual dysphoric disorder; neurotransmitter; serotonin; OVARIAN-STEROIDS; MENSTRUAL-CYCLE; SEX STEROIDS; RISK-FACTORS; YOUNG-WOMEN; SYMPTOMS; METABOLITES; MAGNESIUM; HORMONES; PHASE;
D O I
10.1556/650.2022.32489
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Premenstrual syndrome (PMS) is one of the most common problems for women of reproductive age worldwide, along with painful menstruation and genital inflammation. The physical, mental and behavioural symptoms recur during the luteal phase of the cycle and cause a deterioration in the quality of life, affecting the patient???s social, work and family relationships. Symptoms typically disappear spontaneously within a few days after the onset of menstruation. A severe form of PMS is premenstrual dysphoric disorder (PMDD), which requires psychiatric management. The onset and severity of PMS with multifactorial pathogenesis is triggered by psychoneuroendocrine mechanisms that are influenced by the cyclical functioning of the hypothalamic???pituitary???ovarian axis, altering the neurotransmitter or neuropathway functions of the brain, e.g., the serotoninergic system. The psychoneuroendocrine mechanisms contribute to the development of physical, psychological and behavioural symptoms, which are also influenced by the combined presence of other physiological (genetical background, metabolic and chronic inflammatory processes, chronobiological and circadian disorders) and psychological stressors and their interaction.
引用
收藏
页码:984 / 989
页数:6
相关论文
共 50 条
  • [1] Beneficial role of calcium in premenstrual syndrome: A systematic review of current literature
    Arab, Arman
    Rafie, Nahid
    Askari, Gholamreza
    Taghiabadi, Mina
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2020, 11 (01)
  • [2] Bannister Emma, 2019, Post Reprod Health, V25, P157, DOI 10.1177/2053369119875386
  • [3] REGULATION OF PROGESTIN RECEPTORS IN RAPHE NEURONS OF STEROID-TREATED MONKEYS
    BETHEA, CL
    [J]. NEUROENDOCRINOLOGY, 1994, 60 (01) : 50 - 61
  • [4] Estimating direct and indirect costs of premenstrual syndrome
    Borenstein, J
    Chiou, CF
    Dean, B
    Wong, J
    Wade, S
    [J]. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2005, 47 (01) : 26 - 33
  • [5] BRZEZINSKI AA, 1990, OBSTET GYNECOL, V76, P296
  • [6] CHAN AF, 1994, OBSTET GYNECOL, V84, P1001
  • [7] Dietary B vitamin intake and incident premenstrual syndrome
    Chocano-Bedoya, Patricia O.
    Manson, JoAnn E.
    Hankinson, Susan E.
    Willett, Walter C.
    Johnson, Susan R.
    Chasan-Taber, Lisa
    Ronnenberg, Alayne G.
    Bigelow, Carol
    Bertone-Johnson, Elizabeth R.
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 93 (05) : 1080 - 1086
  • [8] CHUONG CJ, 1990, FERTIL STERIL, V54, P643
  • [9] CHUONG CJ, 1994, FERTIL STERIL, V61, P1039
  • [10] CHUONG CJ, 1994, OBSTET GYNECOL, V83, P755